2091 - 2100 of 8620 Results
Title
Year
-
OPENTitle: Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington diseaseJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-017-0051-5Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-017-0051-5Citation Count: 87
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial2017OPENTitle: Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trialJournal Name: The LancetPublisher: Elsevier BVVol: 390Issue #: 10103Start Page: 1664End Page: 1675Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(17)31585-4Citation Count: 690
-
OPENTitle: Sequential Voluntary Cough and Aspiration or Aspiration Risk in Parkinson’s DiseaseJournal Name: LungPublisher: Springer Science and Business Media LLCVol: 192Issue #: 4Start Page: 601End Page: 608Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00408-014-9584-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4740922Citation Count: 88
- Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies2012OPENTitle: Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodiesJournal Name: mAbsPublisher: Informa UK LimitedVol: 4Issue #: 6Start Page: 686End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.4161/mabs.21696Best OA location URL: https://www.tandfonline.com/doi/pdf/10.4161/mabs.21696?needAccess=trueCitation Count: 68
-
OPENTitle: Hyperplasticity in Autism Spectrum Disorder confers protection from Alzheimer’s diseaseJournal Name: Medical HypothesesPublisher: Elsevier BVVol: 83Issue #: 3Start Page: 337End Page: 342Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.mehy.2014.06.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4392915Citation Count: 46
-
OPENTitle: Repeatability of Aerobic Capacity Measurements in Parkinson DiseaseJournal Name: Medicine & Science in Sports & ExercisePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 43Issue #: 12Start Page: 2381End Page: 2387Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1249/mss.0b013e31822432d4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3701959Citation Count: 45
-
OPENTitle: Two-Pore Channels and Parkinson's Disease: Where's the Link?Journal Name: MessengerPublisher: American Scientific PublishersVol: 5Issue #: 1Start Page: 67End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1166/msr.2016.1051Citation Count: 7
- Osteopontin Expression in the Brain Triggers Localized Inflammation and Cell Death When Immune Cells Are Activated by Pertussis Toxin2014OPENTitle: Osteopontin Expression in the Brain Triggers Localized Inflammation and Cell Death When Immune Cells Are Activated by Pertussis ToxinJournal Name: Mediators of InflammationPublisher: WileyVol: 2014Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2014/358218Best OA location URL: https://downloads.hindawi.com/journals/mi/2014/358218.pdfCitation Count: 10
- Isolation of Murine Postnatal Brain Microglia for Phenotypic Characterization Using Magnetic Cell Separation Technology2013OPENTitle: Isolation of Murine Postnatal Brain Microglia for Phenotypic Characterization Using Magnetic Cell Separation TechnologyJournal Name: Methods in Molecular BiologyPublisher: Humana PressVol:Issue #:Start Page: 33End Page: 39Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-1-62703-520-0_5Best OA location URL: http://doi.org/10.1007/978-1-62703-520-0_5Citation Count: 22
-
OPENTitle: Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson’s DiseaseJournal Name: MetabolitesPublisher: MDPI AGVol: 8Issue #: 4Start Page: 71End Page: 71Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/metabo8040071Best OA location URL: https://www.mdpi.com/2218-1989/8/4/71/pdfCitation Count: 51